Community Screening Study of Diabetic Retinopathy in Tianjin in 2024 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024 — Stella

Home/Diabetic Retinopathy/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Retinopathy trials

Trial locations(1 site)

China

Tianjin Medical University Eye Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Li Xiaorong

Collaborators

Tianjin Medical University Eye Hospital

Enrollment target

~18,000 participants

Started

March 2024

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.